Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: Results from the MEASURE 2 Study

on behalf of the MEASURE 2 Study Group

Research output: Contribution to journalArticlepeer-review

136 Scopus citations

Fingerprint

Dive into the research topics of 'Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: Results from the MEASURE 2 Study'. Together they form a unique fingerprint.

Medicine & Life Sciences